Vjhemonc Podcast
Updates in lower- and higher-risk MDS: challenges, novel agents & key clinical trials at ASH 2023
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:18:17
- More information
Informações:
Synopsis
Myelodysplastic syndromes (MDS) are a heterogeneous group of hematologic neoplasms which can be categorized into lower- and higher-risk disease (LR-MDS;... The post Updates in lower- and higher-risk MDS: challenges, novel agents & key clinical trials at ASH 2023 appeared first on VJHemOnc.
